Correlation Between Unicycive Therapeutics and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Emergent Biosolutions, you can compare the effects of market volatilities on Unicycive Therapeutics and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Emergent Biosolutions.
Diversification Opportunities for Unicycive Therapeutics and Emergent Biosolutions
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Unicycive and Emergent is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Emergent Biosolutions
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.18 times more return on investment than Emergent Biosolutions. However, Unicycive Therapeutics is 1.18 times more volatile than Emergent Biosolutions. It trades about 0.04 of its potential returns per unit of risk. Emergent Biosolutions is currently generating about 0.03 per unit of risk. If you would invest 71.00 in Unicycive Therapeutics on September 5, 2024 and sell it today you would earn a total of 0.00 from holding Unicycive Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Emergent Biosolutions
Performance |
| Timeline |
| Unicycive Therapeutics |
| Emergent Biosolutions |
Unicycive Therapeutics and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Emergent Biosolutions
The main advantage of trading using opposite Unicycive Therapeutics and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Emergent Biosolutions vs. Candel Therapeutics | Emergent Biosolutions vs. Cingulate Warrants | Emergent Biosolutions vs. Unicycive Therapeutics | Emergent Biosolutions vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |